Hepatitis C infection during treatment for childhood cancer: pitfalls in diagnosis and management.
University of Tennessee-Memphis, School of Medicine, Memphis, Tennessee.
Susanna
S
Swilley
Donald K
DK
Strickland
Rene
R
Davila
Mark
M
Levstik
Raul
R
Ribeiro
Melissa M
MM
Hudson
D000740:Anemia / Q000139:chemically induced / Q000628:therapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D005260:Female; D018937:Hepatitis C Antibodies / Q000097:blood; D019698:Hepatitis C, Chronic / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008099:Liver / Q000473:pathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000276:immunology; D012367:RNA, Viral / Q000097:blood; D013997:Time Factors; D065227:Transfusion Reaction; D016896:Treatment Outcome
D000998:Antiviral Agents; D018937:Hepatitis C Antibodies; D016898:Interferon-alpha; D012367:RNA, Viral